[1] 贝政平, 李毅, 王莹, 等. 儿科疾病诊断标准[M]. 北京:科学出版社, 2007. [2] Xu W H, Yang H M, Liu H, et al. Bronchoalveolar lavage T cell cytokine profiles and their association with lung function in children with mycoplasma pneumoniae-associated bronchiolitis obliterans[J]. Pediatric Pulmonology, 2020,55(8):2033-2040. [3] Yu Y F, Wang J, Han R, et al. Mycoplasma hyopneumoniae evades complement activation by binding to factor H via elongation factor thermo unstable (EF-Tu)[J]. Virulence, 2020,11(1):1059-1074. [4] Oishi T, Fukuda Y, Wakabayashi S, et al. Low prevalence of Chlamydia pneumoniae infections during the mycoplasma pneumoniae epidemic season:results of nationwide surveillance in Japan[J]. Journal of Infection and Chemotherapy, 2020,26(11):1116-1121. [5] Varghese S M, Kerkar V V. Macrolide resistant mycoplasma pneumoniae in community acquired pneumonia[J]. The Indian Journal of Pediatrics, 2020,87(11):958. [6] 胡亚美, 江载芳. 诸福棠实用儿科学[M]. 北京:人民卫生出版社, 2005. [7] 霍现洛, 薛小花, 袁淑绘, 等. 胸部CT在2019冠状病毒病和支原体肺炎患者早期鉴别诊断中的价值[J]. 浙江大学学报(医学版), 2020,49(4):468-473. [8] Oliva A, Siccardi G, Migliarini A, et al. Co-infection of SARS-CoV-2 with Chlamydia or mycoplasma pneumoniae:a case series and review of the literature[J]. Infection, 2020,48(6):871-877. [9] 许侃. 小儿肺炎支原体肺炎应用X射线和CT检查的临床价值及影像学特征[J]. 中国妇幼保健, 2020,35(16):3105-3108. [10] Chun Y L, Yu T Y, Chang L Y, et al. Multiple-locus variable-number tandem-repeat analysis (MLVA) of macrolide-susceptible and -resistant mycoplasma pneumoniae in children in Taiwan[J]. Journal of the Formosan Medical Association, 2020,119(10):1539-1545. [11] 李娅, 王倩, 袁刚, 等. 儿童重症肺炎支原体肺炎的CT表现与预后的相关性[J]. 放射学实践, 2020,35(2):234-237. [12] Mirijello A, La Marca A, D'Errico M M, et al. Venous thromboembolism during mycoplasma pneumoniae infection:case report and review of the literature[J]. European Review for Medical and Pharmacological Sciences, 2020,24(19):10061-10068. [13] 王玮, 仲颖岚. CT鉴别小儿肺炎支原体肺炎及肺炎支原体肺炎合并肺炎链球菌性肺炎的价值观察[J]. 中国CT和MRI杂志, 2020,18(12):74-76. [14] Rivaya B, Jordana-Lluch E, Fernández-Rivas G, et al. Macrolide resistance and molecular typing of mycoplasma pneumoniae infections during a 4 year period in Spain[J]. Journal of Antimicrobial Chemotherapy, 2020,75(10):2752-2759. [15] 谢国栋, 邓倩烨, 时晨辉, 等. 低龄肺炎支原体肺炎患儿肺功能变化及HRCT表现特点分析[J]. 中国CT和MRI杂志, 2020,18(10):34-36. [16] Morozumi M, Tajima T, Sakuma M, et al. Sequence type changes associated with decreasing macrolide-resistant mycoplasma pneumoniae, Japan[J]. Emerging Infectious Diseases, 2020,26(9):2210-2213. [17] 孟盈盈, 肖新广, 张欣, 等. 新型冠状病毒肺炎和支原体肺炎的临床及高分辨率CT表现比较[J]. 中国中西医结合影像学杂志, 2020,18(4):325-327, 330. [18] Hubara E, Golan-Tripto I, Ben-Shimol S, et al. Pneumopericardium in a neonate with respiratory syncytial virus and mycoplasma pneumoniae bronchiolitis:an unusual complication with unusual timing[J]. Journal of Paediatrics and Child Health, 2020,56(10):1629-1631. [19] Zhou Y J, Wang J, Chen W J, et al. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory mycoplasma pneumoniae pneumonia[J]. BMC Infectious Diseases, 2020,20(1):633-642. [20] 蔡沁馨, 李红林, 王笑转, 等. 60例成人支原体肺炎的临床及CT影像特征[J]. 暨南大学学报(自然科学与医学版), 2020,41(4):330-335. |